Background: Alzheimer's disease (AD) is a progressive neurodegenerative disease that results in cognitive decline, dementia, and eventually death. Diagnosing early signs of AD can help clinicians to improve the quality of life.
Objective: We developed a non-invasive approach to help neurologists and clinicians to distinguish probable AD patients and healthy controls (HC).